FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2021736794> ?p ?o ?g. }

• W2021736794 endingPage "837" @default.
• W2021736794 startingPage "831" @default.
• W2021736794 abstract "Objective To determine the incidence of ovarian failure after cyclophosphamide (CYC) treatment for systemic lupus erythematosus (SLE) and to identify the risk factors for this complication. Methods The records of 70 premenopausal female SLE patients treated with CYC were reviewed retrospectively. Information on demographic features, autoantibody profiles, and CYC treatment was obtained, and comparisons were made between those who developed ovarian failure and those who did not. Data on the CYC-treated patients were also compared with data on 2 control groups of non-CYC-treated SLE patients. Results Eighteen patients developed ovarian failure after CYC treatment, for an overall incidence of 26%. The incidence of ovarian failure showed a linear trend of increase with increasing age at the start of CYC (P = 0.007). The cumulative CYC dose was significantly higher in the patients with ovarian failure than in those without (28.3 gm versus 15.4 gm; P = 0.004). The risk of ovarian failure also showed a linear trend of increase with increasing cumulative CYC dose (P < 0.001). Using multiple logistic regression, the age at the time of CYC treatment initiation (β = 0.37, SE = 0.11, P = 0.001) and the cumulative dose of CYC received (β = 0.69, SE = 0.29, P = 0.02) were found to be independent risk factors for CYC-induced ovarian failure. Conclusion In our population of female SLE patients, CYC-induced ovarian toxicity is a significant problem, particularly in patients above the age of 40. The age at the start of CYC therapy and the cumulative dose are the major determinants for the development of this complication. For older patients with SLE in whom the use of CYC is warranted, a shorter course and lower dosage should be considered." @default.
• W2021736794 created "2016-06-24" @default.
• W2021736794 creator A5004488408 @default.
• W2021736794 creator A5033947419 @default.
• W2021736794 creator A5073058414 @default.
• W2021736794 date "1998-05-01" @default.
• W2021736794 modified "2023-10-14" @default.
• W2021736794 title "Risk factors for ovarian failure in patients with systemic lupus erythematosus receiving cyclophosphamide therapy" @default.
• W2021736794 cites W119919271 @default.
• W2021736794 cites W1971058219 @default.
• W2021736794 cites W1991607336 @default.
• W2021736794 cites W2003089769 @default.
• W2021736794 cites W2012717397 @default.
• W2021736794 cites W2021942428 @default.
• W2021736794 cites W2029308711 @default.
• W2021736794 cites W2032501682 @default.
• W2021736794 cites W2039709079 @default.
• W2021736794 cites W2045852320 @default.
• W2021736794 cites W2049831025 @default.
• W2021736794 cites W2053582855 @default.
• W2021736794 cites W2068833343 @default.
• W2021736794 cites W2072487355 @default.
• W2021736794 cites W2077421566 @default.
• W2021736794 cites W2080455790 @default.
• W2021736794 cites W2084712312 @default.
• W2021736794 cites W2086355654 @default.
• W2021736794 cites W2134422076 @default.
• W2021736794 cites W2145136871 @default.
• W2021736794 cites W2146203649 @default.
• W2021736794 cites W2152860648 @default.
• W2021736794 cites W2162388356 @default.
• W2021736794 cites W2166144559 @default.
• W2021736794 cites W2320158368 @default.
• W2021736794 cites W2325870812 @default.
• W2021736794 cites W2335138225 @default.
• W2021736794 cites W2972987 @default.
• W2021736794 doi "https://doi.org/10.1002/1529-0131(199805)41:5<831::aid-art9>3.0.co;2-1" @default.
• W2021736794 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/9588734" @default.
• W2021736794 hasPublicationYear "1998" @default.
• W2021736794 type Work @default.
• W2021736794 sameAs 2021736794 @default.
• W2021736794 citedByCount "192" @default.
• W2021736794 countsByYear W20217367942012 @default.
• W2021736794 countsByYear W20217367942013 @default.
• W2021736794 countsByYear W20217367942014 @default.
• W2021736794 countsByYear W20217367942015 @default.
• W2021736794 countsByYear W20217367942016 @default.
• W2021736794 countsByYear W20217367942017 @default.
• W2021736794 countsByYear W20217367942018 @default.
• W2021736794 countsByYear W20217367942019 @default.
• W2021736794 countsByYear W20217367942020 @default.
• W2021736794 countsByYear W20217367942021 @default.
• W2021736794 countsByYear W20217367942022 @default.
• W2021736794 countsByYear W20217367942023 @default.
• W2021736794 crossrefType "journal-article" @default.
• W2021736794 hasAuthorship W2021736794A5004488408 @default.
• W2021736794 hasAuthorship W2021736794A5033947419 @default.
• W2021736794 hasAuthorship W2021736794A5073058414 @default.
• W2021736794 hasConcept C120665830 @default.
• W2021736794 hasConcept C121332964 @default.
• W2021736794 hasConcept C126322002 @default.
• W2021736794 hasConcept C151032500 @default.
• W2021736794 hasConcept C151956035 @default.
• W2021736794 hasConcept C2776694085 @default.
• W2021736794 hasConcept C2776755627 @default.
• W2021736794 hasConcept C2908647359 @default.
• W2021736794 hasConcept C61511704 @default.
• W2021736794 hasConcept C71924100 @default.
• W2021736794 hasConcept C72563966 @default.
• W2021736794 hasConcept C88879693 @default.
• W2021736794 hasConcept C90924648 @default.
• W2021736794 hasConcept C99454951 @default.
• W2021736794 hasConceptScore W2021736794C120665830 @default.
• W2021736794 hasConceptScore W2021736794C121332964 @default.
• W2021736794 hasConceptScore W2021736794C126322002 @default.
• W2021736794 hasConceptScore W2021736794C151032500 @default.
• W2021736794 hasConceptScore W2021736794C151956035 @default.
• W2021736794 hasConceptScore W2021736794C2776694085 @default.
• W2021736794 hasConceptScore W2021736794C2776755627 @default.
• W2021736794 hasConceptScore W2021736794C2908647359 @default.
• W2021736794 hasConceptScore W2021736794C61511704 @default.
• W2021736794 hasConceptScore W2021736794C71924100 @default.
• W2021736794 hasConceptScore W2021736794C72563966 @default.
• W2021736794 hasConceptScore W2021736794C88879693 @default.
• W2021736794 hasConceptScore W2021736794C90924648 @default.
• W2021736794 hasConceptScore W2021736794C99454951 @default.
• W2021736794 hasIssue "5" @default.
• W2021736794 hasLocation W20217367941 @default.
• W2021736794 hasLocation W20217367942 @default.
• W2021736794 hasOpenAccess W2021736794 @default.
• W2021736794 hasPrimaryLocation W20217367941 @default.
• W2021736794 hasRelatedWork W1967134323 @default.
• W2021736794 hasRelatedWork W2021736794 @default.
• W2021736794 hasRelatedWork W2117784457 @default.
• W2021736794 hasRelatedWork W2149708286 @default.
• W2021736794 hasRelatedWork W2275480158 @default.
• W2021736794 hasRelatedWork W2305447501 @default.
• W2021736794 hasRelatedWork W2415666441 @default.

• next